Genentech Newswire

Comprehensive Real-Time News Feed for Genentech.

Results 1 - 20 of 261 in Genentech

  1. Galena Biopharma Appoints Mark W. Schwartz, Ph.D., as President and Chief Executive OfficerRead the original story

    5 hrs ago | GlobeNewswire

    ... DNA vaccine platform for the treatment of autoimmune diseases where he completed a successful partnership with Genentech for the development of the company's Type 1 diabetes vaccine. He had also served as President and CEO of Calyx Therapeutics, ...

    Comment?

  2. Galena Biopharma Taps A New President And CEORead the original story

    5 hrs ago | BioSpace

    ... DNA vaccine platform for the treatment of autoimmune diseases where he completed a successful partnership with Genentech for the development of the company's Type 1 diabetes vaccine. He had also served as President and CEO of Calyx Therapeutics, ...

    Comment?

  3. Efficacy and Safety of Omalizumab in Patients with Chronic...Read the original story

    9 hrs ago | The Journal of Investigative Dermatology

    Correspondence: Karin Rosén, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080-4990, USA.

    Comment?

  4. USC Eye Institute study finds African-Americans at higher risk for diabetic vision lossRead the original story w/Photo

    Yesterday | EurekAlert!

    ... The study, "Prevalence of and risk factors for diabetic macular edema in the United States," was funded by Genentech, a pharmaceutical company. Varma is a consultant for Genentech. The research team includes scientists from the Wilmer Eye Institute ...

    Comment?

  5. Chugai Advances Most Since 2000; Roche Said to Mull BuyoutRead the original story

    Monday Aug 18 | The Washington Post

    ... has been made, one of the people said. The acquisition would be Roche's largest since the $44 billion deal for Genentech Inc. in 2008, and would bring the Swiss drugmaker's total this year to the most since then, according to data compiled by ...

    Comment?

  6. UPDATE 1-Shares in Japan's Chugai surge on report of Roche buyout offerRead the original story

    Monday Aug 18 | Reuters

    ... of cancer medicines, might swallow Chugai had swirled after Roche made a similar buyout of U.S. biotech group Genentech in 2009. But Roche and Chugai have made repeated denials. Chugai's valuations - whether measured by price-to-earnings, ...

    Comment?

  7. Alzheimer's drug misses goalsRead the original story

    Saturday Aug 16 | The Daily Record

    An experimental drug from the biotech company Genentech failed to slow mental decline in mid-stage studies on more than 500 people with mild to moderate Alzheimer's disease, but showed some promise in the least-impaired participants who received a higher dose.

    Comment?

  8. Roche to offer $10 billion for rest of Chugai: BloombergRead the original story

    Friday Aug 15 | MSN Money

    ... There has long been speculation that Roche might swallow Chugai - following a similar buyout of U.S. biotech group Genentech in 2009 - to maximize exposure to the Japanese drugs market, the world's second largest after the United States. Roche Chief ...

    Comment?

  9. Gilead beats back Roche, wins U.K. victory for hepatitis C drug SovaldiRead the original story w/Photo

    Friday Aug 15 | Business Journal

    ... more than $11 billion in sales in its first year. Beating Roche, the Swiss parent company of South San Francisco Genentech Inc. , in arbitration eliminated a "disaster scenario" for Sovaldi, Cowen Group analyst Phil Nadeau said, according to CNBC. ...

    Comment?

  10. Array Biopharma Inc - 10-K - Management's Discussion and Analysis of...Read the original story

    Friday Aug 15 | Hispanic Business

    ... for cancer AstraZeneca, PLC Phase 3 for gastric cancer Pte Ltd. 4. Ipatasertib/GDC-0068 AKT inhibitor for cancer Genentech, Inc. Phase 2 5. VTX-2337 Toll-like receptor for VentiRx Phase 2 cancer Pharmaceuticals, Inc. 6. Danoprevir Hepatitis C virus ...

    Comment?

  11. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Thursday Aug 14 | Business Wire

    ... Unified School District School Facilities improvement District No. 1, California (the SFID) genera... )--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved ...

    Comment?

  12. Genentech wins approval to treat advanced cervical cancerRead the original story w/Photo

    Thursday Aug 14 | Seattle Post-Intelligencer

    Genentech scored its latest victory Thursday when its drug Avastin won federal approval to treat yet another cancer, advanced cervical cancer.

    Comment?

  13. Richard Scheller's rare African art heading to de YoungRead the original story

    Thursday Aug 14 | SFGate

    A rare collection of African art assembled over nearly 30 years by a leading Genentech biochemist will go on display at the de Young Museum in Golden Gate Park in late January, marking the first time the public has seen many of the carved forms and shapes.

    Comment?

  14. Richard Scheller's rare African art head to de YoungRead the original story

    Thursday Aug 14 | SFGate

    A rare collection of African art assembled over nearly 30 years by a leading Genentech biochemist will go on display at the de Young Museum in Golden Gate Park in late January, marking the first time the public has seen many of the carved forms and shapes.

    Comment?

  15. Suitors line up for lung drug developer InterMuneRead the original story w/Photo

    Wednesday Aug 13 | Business Journal

    ... and Centerview Partners to help it weigh the bids, Bloomberg reported Wednesday . Those suitors reportedly include Genentech Inc. parent Roche Holding AG, Sanofi, GlaxoSmtihKline and Actelion Ltd. InterMune stock jumped $6.57 per share Wednesday, or ...

    Comment?

  16. Google 'anti-aging' group Calico has a websiteRead the original story w/Photo

    Wednesday Aug 13 | New York Daily News

    ... lives." As previously announced, the head of the company is Arthur Levinson, who was chief executive officer of Genentech from 1995 to 2009 and is now the chairman of the board of Apple. The other members of the team, which had not been previously ...

    Comment?

  17. Google 'anti-aging' group has a websiteRead the original story w/Photo

    Wednesday Aug 13 | Yahoo!

    ... lives." As previously announced, the head of the company is Arthur Levinson, who was chief executive officer of Genentech from 1995 to 2009 and is now the chairman of the board of Apple. The other members of the team, which had not been previously ...

    Comment?

  18. Google opens 'anti-ageing' websiteRead the original story w/Photo

    Tuesday Aug 12 | Bangkok Post

    ... lives." As previously announced, the head of the company is Arthur Levinson, who was chief executive officer of Genentech from 1995 to 2009 and is now the chairman of the board of Apple. The other members of the team, which had not been previously ...

    Comment?

  19. Google's Company That Wants To Cure Death Now Has Its Own WebsiteRead the original story w/Photo

    Tuesday Aug 12 | Silicon Alley Insider

    ... of interdisciplinary effort and a long-term focus for which funding is already in place." Art Levinson, former Genentech CEO and chairman of Apple, would be leading the charge. Now, we see that he'll be joined by Hal Barron, former executive VP and ...

    Comment?

  20. Seattle Genetics Initiates Phase 1 Clinical Trial of Antibody-Drug...Read the original story

    Tuesday Aug 12 | Business Wire

    ... leading biotechnology and pharmaceutical companies, including AbbVie, Agensys (an affiliate of Astellas), Bayer, Genentech, GlaxoSmithKline and Pfizer. More information can be found at www.seattlegenetics.com . Certain of the statements made in this ...

    Comment?